Year: 2024
Type: article
Abstract: Lauren Coyle, Commissioning Editor, Cell & Gene Therapy Insights, speaks with Dhruv Sareen, Executive Director at Cedars-Sinai Biomanufacturing Center, and Johnathan Rodriguez, Quality Control Manager at Cedars-Sinai Biomanufacturing Center, about the roles of in-process controls, method validation, risk management, and automation in biomanufacturing. They will highlight strategies to ensure product safety, consistency, and regulatory compliance for cell and gene therapy products.
Source: Cell and Gene Therapy Insights
Authors: Dhruv Sareen, Johnathan Rodriguez
Institution: Cedars-Sinai Medical Center
Language: English
Topic: CAR-T cell therapy research
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: hybrid
Funder: Cedars-Sinai Medical Center
OpenAlex ID: W7115584838
FWCI:
Cites:
Cited by:
Related to: